HRL
47
2
URI
50
7
NWL
61
3
PFE
50
2
M
37
-3
KMB
45
-3
AEP
64
-3
UNH
37
4
GIS
57
2
PAYX
45
7
OI
50
-5
CFG
89
4
PNC
75
6
AMGN
41
3
CLX
53
-2
HOG
45
3
NEE
75
4
MSFT
40
-4
DLTR
63
5
ADBE
44
3
HRL
47
2
URI
50
7
NWL
61
3
PFE
50
2
M
37
-3
KMB
45
-3
AEP
64
-3
UNH
37
4
GIS
57
2
PAYX
45
7
OI
50
-5
CFG
89
4
PNC
75
6
AMGN
41
3
CLX
53
-2
HOG
45
3
NEE
75
4
MSFT
40
-4
DLTR
63
5
ADBE
44
3
Financhill
Back

Inovio Pharmaceuticals, Inc. 10K Form

Sell
37

INO
Inovio Pharmaceuticals, Inc.

Last Price:
$2.03
Seasonality Move:
9.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INO News And Ratings

See the #1 stock for the next 7 days that we like better than INO

INO Financial Statistics

Sales & Book Value

Annual Sales: $217.8K
Cash Flow: $-21.6M
Price / Cash Flow: 0
Annual Sales: $-0.14
Price / Book: 3.73

Profitability

EPS (TTM): -2.58490
Net Income (TTM): $-108.1M
Gross Margin: $-2.9M
Return on Equity: -252.43%
Return on Assets: -120.95%

Inovio Pharmaceuticals, Inc. Earnings Forecast

Key Inovio Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 26 years for INO is -1,337.14%.
  • The Selling, General & Administrative Expenses for INO have been equal to 16,986.36% of Gross Profit Margin.
  • The Research & Development expenses have been 35,454.68% of Revenue.
  • The Net Earning history of INO is -49,244.31% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Inovio Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INO
CUSIP: 45773H
Website: inovio.com

Debt

Debt-to-Equity Ratio: -1.3
Current Ratio: 0.79
Quick Ratio: 0.74

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INO Technical Analysis vs Fundamental Analysis

Sell
37
Inovio Pharmaceuticals, Inc. (INO) is a Sell

Is Inovio Pharmaceuticals, Inc. a Buy or a Sell?